Tech Company Financing Transactions
Elevation Pharmaceuticals Funding Round
Canaan Partners, Care Capital and Mesa Verde Venture Partners participated in a $17 million Series A capital raise for Elevation Pharmaceuticals. The round was announced by the company on 9/26/2011.
Transaction Overview
Company Name
Announced On
9/26/2011
Transaction Type
Venture Equity
Amount
$17,000,000
Round
Series A
Investors
Proceeds Purpose
The funding will be used to pay for an ongoing mid-stage study of its experimental drug EP-101.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
11455 El Camino Real 460
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
Founded in 2008, Elevation Pharmaceuticals is developing a pipeline of improved aerosol drug products for COPD patients. Our founding team has a successful track record starting companies and building dedicated teams to develop new drug products that improve patients' lives.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bill Gerhart
Chief Medical Officer
Ahmet Tutuncu
Chief Technical Officer
Pravin Soni
VP - Bus. Development
Jaisim Shah
Browse more venture capital transactions:
Prev: 9/26/2011: Quantance venture capital transaction
Next: 9/26/2011: ioRevolution venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs